Pharmaceutical intermediates sales will expand through 2036, with chemical intermediates at 58.5% of product demand in 2026. The market was valued at USD 36.62 billion in 2025, is projected to reach USD 59.43 billion by 2036 and is forecast to record a 4.5% CAGR between 2026 and 2036.